XXXXXXXXX XXXXXXXXXX XXXXXX (XX) 2020/528
xx xxx 14. xxxxx 2020,
kterým xx xxxxxxxxx xxxxxxxxxx x Xxxxxxxx, Xxxx, Xxxxx Xxxxxx, Xxxxxxxxx xxxxxxx x Xxxxxxx xx xxxxxx provádění xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx x xxx, xxxxx x xxxxxx
(xxxxxxxx xxx xxxxxx X(2020) 2103)
(Xxxx x xxxxxxxx xxx EHP)
EVROPSKÁ XXXXXX,
x xxxxxxx na Smlouvu x xxxxxxxxx Xxxxxxxx xxxx,
x xxxxxxx xx xxxxxxxxxx Rady 2000/258/XX xx xxx 20. xxxxxx 2000 o xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxxxxx xx xxxxxxxxx xxxxxxxx xxxxxxxxxx xxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx účinnosti xxxxxxxxxx xxxxx proti xxxxxxxxx&xxxx;(1), x xxxxxxx xx xx. 3 xxxx. 2 xxxxxxxxx xxxxxxxxxx,
xxxxxxxx x těmto xxxxxxx:
|
(1) |
Xxxxxxxxxx 2000/258/XX xxxxxx xxxxxxxxx Agence xxxxçxxxx xx xxxxxxxx xxxxxxxxx xxx aliments (dále xxx „XXXXX“) xx xxxxxxxxxxxx Xxxxx xxxx xxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxxxx xxxxxxxx xxxxxxxxxx xxx normalizaci xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx. XXXXX byla nyní xxxxxxxxx do Agence xxxxxxxxx xx xxxxxxxx xxxxxxxxx de l’alimentation, xx l’environnement et xx travail (xxxx xxx „XXXXX“) xx Xxxxxxx. |
|
(2) |
Xxxxxxxxxx 2000/258/XX mimo xxxx stanoví, xx XXXXX xxxxxxx laboratoře xx třetích xxxxxx, xxxxx xxxxxxxxxx xxxxxx x schválení xx xxxxxx provádění xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx očkovacích xxxxx xxxxx xxxxxxxxx. |
|
(3) |
Xxxxxxxxx xxxxx x Xxxxxxxx xxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxxxxx „Xxxxxx de Xxxxxxxxx xx Xxxxx xx Xxxxxxxxxxx de Xxxxxxxxx Clínica e Xxxxxxxxx xx Xxxxxxxxx xx Xxêxxxxx Xxxxxxxxxx xx Xxxxxxxxxxxx xx Xãx Xxxxx“. ANSES xxx xxxx laboratoř xxxxxxxxxxx příznivou xxxxxxxxx xxxxxx xx xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(4) |
Xxxxxxxxx xxxxx Xxxx xxxxxxxxx xxxxxx x xxxxxxxxx xxxx xxxxxxxxxx: „Sino Xxxx World Xxxxxxxxxxx Xxxxxxxxxxxxxx Xx., Ltd (Xxxxxx)“ x „Animal Xxxxxxx Xxxxxxxxxx Center xx xxx Xxxxxxxxx xx Xxxxxx Xxxxxx xx the Guangdong Xxxxxxx of Xxxxxxxxxxx Xxxxxxxx“. XXXXX pro xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx dne 24. xxxxx 2019, kterou xxxxxxxxxx Komisi. |
|
(5) |
Příslušný xxxxx Xxxx předložil xxxxxx x xxxxxxxx schválení xxxx xxxxxxxxxx: „National Xxxxxxxxx Xxxxxxxxxx xxx Xxxxxx Xxxxxx (Diagnostic Xxxxxxxxxx xxx Xxxxxx xxx Xxxxxxxx Associated Xxxxxxxx)“ x „Xxxxxx xxx Xxxxxx Xxxxxxxx Xxxxx xx xxx Xxxxxxxxxx xx Xxxxxxxxxxxx xx xxx Xxxxxxxx Xxxxxxxxxx Xxxxxxxx Institute xx the Xxxxxxx xx Xxxxxxxx Xxxxxxx Xxxxxxxx“. XXXXX xxx xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx xxx 24. xxxxx 2019, kterou xxxxxxxxxx Xxxxxx. |
|
(6) |
Xxxxxxxxx xxxxx Xxxxx Koreje xxxxxxxxx xxxxxx o schválení xxxxxxxxxx „Xxxxxx xxx Xxxxxxxx encephalitis OIE xxxxxxxxx laboratory xx Xxxxxx xxx Plant Xxxxxxxxxx Xxxxxx“. XXXXX xxx tuto xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx xxx 24. xxxxx 2019, xxxxxx předložila Xxxxxx. |
|
(7) |
Xxxxxxxxx xxxxx Thajska xxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxxxxx „Xxxxxxxx Institute xx Xxxxxx Xxxxxx“. XXXXX xxx xxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx ze xxx 24. xxxxx 2019, xxxxxx předložila Xxxxxx. |
|
(8) |
Xxxxxxxxx xxxxx Spojených xxxxx předložil žádost x xxxxxxxx schválení xxxxxxxxxx „Xxxxxxx xxx Xxxxxxx Xxxxxxx xxx Xxxxxxxxxx of xxx Xxxxxx Laboratory“. ANSES xxx xxxx laboratoř xxxxxxxxxxx xxxxxxxxx hodnotící xxxxxx xx xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Komisi. |
|
(9) |
Tyto xxxxxxxxxx xx xxxxx xxxx být schváleny xx xxxxxx provádění xxxxxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx vzteklině x xxx, xxxxx x fretek. |
|
(10) |
Opatření stanovená xxxxx xxxxxxxxxxx xxxx x xxxxxxx se xxxxxxxxxxx Stálého výboru xxx xxxxxxxx, xxxxxxx, xxxxxxxxx a xxxxxx, |
XXXXXXX XXXX ROZHODNUTÍ:
Xxxxxx 1
V xxxxxxx x čl. 3 xxxx. 2 xxxxxxxxxx 2000/258/XX se xxx xxxxxxxxx xxxxxxxxxxxxx testů xx xxxxxx xxxxxxxxx xxxxxxxxx očkovacích xxxxx xxxxx xxxxxxxxx u xxx, xxxxx x xxxxxx xxxxxxxxx xxxx xxxxxxxxxx:
|
x) |
Xxxxxx de Xxxxxxxxx xx Raiva Laboratório xx Xxxxxxxxx Xxxxxxx e Xxxxxxxxx xx Xxxxxxxxx xx Xxêxxxxx Biomédicas Universidade xx Xãx Xxxxx Av. Xxxx. Xxxxx Prestes, 1374, room 225 05508-000 Xãx Xxxxx Xxxxxxxx |
|
b) |
Sino Xxxx Xxxxx Xxxxxxxxxxx Xxxxxxxxxxxxxx Xx., Xxx (Xxxxxxx) 29 Xxxxxxxx Xxxx Xxxx. Xxxxxxxxxx Medicine Base, Xxxxxx Xxxxxxxx, Xxxxxx Čína |
|
c) |
Animal Xxxxxxx Xxxxxxxxxx Center Institute xx Xxxxxx Health, Guangdong Xxxxxxx xx Xxxxxxxxxxx Xxxxxxxx 21 Baishigang Street, Xxxxxx District Xxxxxxxxx, Xxxxxxxxx Xxxx |
|
d) |
National Xxxxxxxxx Xxxxxxxxxx xxx Xxxxxx Rabies (Xxxxxxxxxx Xxxxxxxxxx xxx Xxxxxx xxx Xxxxxxxx Associated Xxxxxxxx) Xxxxxxxxx Veterinary Xxxxxxxx Xxxxxxxxx, Xxxxxxx Academy xx Xxxxxxxxxxxx Xxxxxxxx 666 Xxxxxxx Xxxx Road, Xxxxxxx Xxxxxxx Development Xxxxxxxx, Xxxxxxxxx, Xxxxx, Xxxx |
|
x) |
Xxxxxx xxx Xxxxxx Antibody Xxxxx, Laboratory xx Xxxxxxxxxxxx, Xxxxxxxx Veterinary Xxxxxxxx Xxxxxxxxx, Xxxxxxx xx Military Xxxxxxx Xxxxxxxx 666 Liuying West Xxxx, Xxxxxxx Economy Xxxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Xxxxx Xxxx |
|
f) |
Rabies xxx Japanese xxxxxxxxxxxx XXX reference laboratory xx xxx Animal xxx Xxxxx Xxxxxxxxxx Xxxxxx 177 Xxxxxxxx 8-xx, Xxxxxxxx-xx, Xxxxxxxxxxxxx-xx, 39660, Xxxxx Xxxxx |
|
x) |
Xxxxxxx for Disease Xxxxxxx xxx Xxxxxxxxxx Xxxxxx Xxxxxxxxxx 1600 Clifton Road, XX, Atlanta, XX 30333, Xxxxxxx xxxxx xxxxxxxx |
|
x) |
The Xxxxxxxx Institute xx Xxxxxx Xxxxxx 50/2 Xxxxxxxxxx, Xxxxxx, Xxxxxxxxx Xxxxxxx 10900 Xxxxxxx |
Xxxxxx 2
Xxxx rozhodnutí xx xxxxxx členským xxxxxx.
X Xxxxxxx xxx 14. xxxxx 2020.
Za Xxxxxx
Xxxxxx XXXXXXXXXX
xxxxxx Xxxxxx
(1) Úř. xxxx. X 79, 30.3.2000, x. 40.